A. Stein, “Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: Results of a multicenter phase I/II study”, AO, vol. 53, no. 3, pp. 392–398, Mar. 2014.